[Closed for Investment] WinSanTor, with a valuation cap of $75 million, is raising funds on StartEngine. The company is focused on developing drugs for the treatment of diabetic peripheral neuropathy. The first drug of WinSanTor is in the clinical trial and is expected to reach the patients in the next three years. The class of drugs discovered by WinSanTor scientists increases ATP production in the affected nerves and increases their growth. WinSanTor was founded by Paul Fernyhough, Nigel Calcutt, and Lakshmi Kotra and has already received over $25 million in peer-reviewed grants. The current round of crowdfunding has a minimum goal of $10,000 and a maximum goal of $535,000, and the funds will be used to complete the Phase 2 trials and prepare for the Phase 3 clinical trials. WinSanTor is bringing about a breakthrough in science, and its drugs could be the only disease-modifying treatment for any form of peripheral neuropathy.
Investment Overview
Raised: $32,651
Deal Terms
Total Commitments ($USD)
- Platform
- StartEngine
- Start Date
- 03/13/2020
- Close Date
- 04/28/2020
$10,000
$535,000
$500
Convertible Note
RegCF
$75,000,000
0%
Company & Team
Company
- Year Founded
- 2011
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Location
- San Diego, California
- Company Website
-
Visit Website
Team
- Employees
- 5
Financials
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 04/29/2024 | Wefunder | $500,000,000 | $193,502 | SAFE | Funded | RegCF |
| 04/28/2020 | StartEngine | $75,000,000 | $32,651 | Convertible Note | Not Funded | RegCF |
| 03/20/2019 | Wefunder | $70,000,000 | $596,649 | SAFE | Funded | RegCF |
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.